rop-et: a phase iii non-randomized study of ropeginterferon alfa-2b in patients with et
Published 2 months ago • 90 plays • Length 0:56Download video MP4
Download video MP3
Similar videos
-
1:49
current and future therapies for pv: ropeginterferon alfa-2b
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:30
results of the ruxopeg trial: combining ruxolitinib and interferon in patients with myelofibrosis
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
2:58
results of a phase ib study of ibrutinib obinutuzumab in r/r cll
-
1:37
a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
-
3:56
iontorrent™原理
-
15:59
phylogenomic branch length estimation using... - yasamin tabatabaee - evolcompgen - ismb/eccb 2023
-
9:25
mgus diagnosis: a step-by-step approach
-
1:19
telomerase inhibition as a novel targeted therapy for myelofibrosis
-
2:41
a phase i/ii study of afm13 in combination with cord blood-derived nk cells in patients with r/r hl
-
2:13
splicing mutations in post-et/post-pv myelofibrosis
-
1:24
phase i study of cd123 nk cell engager sar443579 in r/r aml, b-all or hr-mds
-
3:21
a phase i trial of hu8f4, an anti-pr1/hla-a2 monoclonal antibody, in r/r myeloid malignancies
-
2:40
the role of consolidation therapy in mm and updates from the emn02 trial
-
1:22
long-term follow-up results of tourmaline-mm2: ird vs pbo-rd in multiple myeloma
-
5:07
daratumumab in the management of al amyloidosis
-
2:43
gemtuzumab ozogamicin in frontline aml therapy
-
1:28
the role of allogeneic transplantation in patients with aml in the frontline setting
-
4:58
findings of a phase i study of anitocabtagene autoleucel for the treatment of r/r myeloma
-
3:36
outcomes of patients with newly diagnosed crlf2-rearranged b-all